Page last updated: 2024-08-23

1-deoxynojirimycin and amantadine

1-deoxynojirimycin has been researched along with amantadine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Codd, R; Liao, V; Lifa, T; Liu, J; Obando, D	1
Griffin, S; Harris, M; Owsianka, AM; Patel, AH; Rowlands, D; Stgelais, C	1

Reviews

1 review(s) available for 1-deoxynojirimycin and amantadine

Article	Year
The many faces of the adamantyl group in drug design. European journal of medicinal chemistry, 2011, Volume: 46, Issue:6 Topics: Adamantane; Animals; Antimalarials; Diabetes Mellitus, Type 2; Drug Design; Humans; Hypoglycemic Agents; Iron Chelating Agents; Iron Overload; Malaria; Solubility	2011

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and amantadine

Article	Year
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:6 Topics: 1-Deoxynojirimycin; Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Molecular Sequence Data; Rimantadine; Viral Proteins; Virus Replication	2008

Article

Year

Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.

Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:6

Topics: 1-Deoxynojirimycin; Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Molecular Sequence Data; Rimantadine; Viral Proteins; Virus Replication

2008